M2M Capital Invests in GenpharmaChain to Drive AI and Web3-Powered Drug Development
Llanymynech, United Kingdom Dec 19, 2024 (Issuewire.com) - M2M Capital Invests in GenpharmaChain to Drive AI and Web3-Powered Drug Development
GenPharmaChain, a pioneering AI-driven biotech Web3 platform, has secured a strategic investment from M2M Capital. The funding will accelerate GenPharmaChains mission to harness AI and blockchain technologies for transformative advancements in drug discovery and development.
With a robust database comprising over 200 million protein sequences and extensive disease-related data, GenPharmaChain seeks to revolutionize the pharmaceutical industry. By integrating decentralized platforms, the company aims to enable faster, more secure, and transparent drug development processes.
About M2M Capital
M2M Capital is a leading venture capital firm specializing in investments across cutting-edge sectors, including blockchain, AI, and Web3 technologies. The firms portfolio includes notable innovators such as Panda Titan and Nexgendex, underscoring its commitment to driving groundbreaking advancements in technology.
Media Contact
More On 101broadcast ::
- Upgrade Your Space with AMD Remodeling: Exceptional Home Renovations for Dallas and Surrounding Areas
- Terri Deming, Recognized by BestAgents.us as a 2025 Top Agent
- Sanford Head Of School Mark Anderson Resigns Amid Recent Scandal and Controversy
- Raven Resources Corp. Provides Interim Financing for Serenata Beach Club
- Charlene Bury, Recognized by BestAgents.us as a 2025 Top Agent
genpharmachain
Source :Genpharmachain and M2M Capital
This article was originally published by IssueWire. Read the original article here.